| Product NDC: | 0469-5201 |
| Proprietary Name: | Protopic |
| Non Proprietary Name: | Tacrolimus |
| Active Ingredient(s): | .3 mg/g & nbsp; Tacrolimus |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0469-5201 |
| Labeler Name: | Astellas Pharma US Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050777 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001208 |
| Package NDC: | 0469-5201-02 |
| Package Description: | 1 TUBE in 1 CARTON (0469-5201-02) > 2 g in 1 TUBE |
| NDC Code | 0469-5201-02 |
| Proprietary Name | Protopic |
| Package Description | 1 TUBE in 1 CARTON (0469-5201-02) > 2 g in 1 TUBE |
| Product NDC | 0469-5201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tacrolimus |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20001208 |
| Marketing Category Name | NDA |
| Labeler Name | Astellas Pharma US Inc. |
| Substance Name | TACROLIMUS |
| Strength Number | .3 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |